Search
The DAT Shift: What’s Pulling Biotech Firms Into the Crypto Treasury Game?
3.9.2025
2025 has shaped up to be a defining year for the emerging digital asset treasury movement, widely referred to as DATs. Research indicates that more than 100 publicly traded firms have embraced the DAT strategy, with a significant portion of them in the biotech sector—a field grappling with...
Windtree’s BNB Treasury Bet Collides With Nasdaq Delisting Order
21.8.2025
Biotech firm Windtree touted itself as the first Nasdaq-listed company to build a BNB treasury. Weeks later, the Securities and Exchange Commission ordered it delisted
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
29.7.2025
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
29.7.2025
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
29.7.2025
The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders
Kraken to Support Biotech Firm Windtree’s $200M BNB Treasury Play
22.7.2025
Crypto exchange Kraken will custody and manage BNB assets for Windtree Therapeutics' crypto treasury plan tied to Binance Chain
Biotech firm Sonnet to form $888M HYPE treasury
14.7.2025
Biotech firm Sonnet is merging with Rorschach to form Hyperliquid Strategies, which aims to become HYPE token’s largest United States-listed holder
Biotech firm Sonnet to form $888M HYPE treasury
14.7.2025
Biotech firm Sonnet is merging with Rorschach to form Hyperliquid Strategies, which aims to become HYPE token’s largest United States-listed holder
Biotech firm Sonnet to form $888M HYPE treasury
14.7.2025
Biotech firm Sonnet is merging with Rorschach to form Hyperliquid Strategies, which aims to become HYPE token’s largest United States-listed holder
Biotech firm Sonnet to form $888M HYPE treasury
14.7.2025
Biotech firm Sonnet is merging with Rorschach to form Hyperliquid Strategies, which aims to become HYPE token’s largest United States-listed holder
A South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin Treasury
20.6.2025
The company is also preparing to list on public markets in the U.S. via a special purpose acquisition company, SilverBox Corp IV
Korean biotech firm bought by Parataxis for Bitcoin treasury use
20.6.2025
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers
Korean biotech firm bought by Parataxis for Bitcoin treasury use
20.6.2025
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers
Korean biotech firm bought by Parataxis for Bitcoin treasury use
20.6.2025
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers
Korean biotech firm bought by Parataxis for Bitcoin treasury use
20.6.2025
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers
Korean biotech firm bought by Parataxis for Bitcoin treasury use
20.6.2025
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers
Korean biotech firm bought by Parataxis for Bitcoin treasury use
20.6.2025
Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers
Biopharma exec says Bitcoin could help industry through ‘biotech winter’
21.3.2025
NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals. Atai, which is developing mental health treatments using psychedelics like DMT and MDMA, has become...
Biotech's ATAI Life Sciences Joins Roster of Firms With Bitcoin Treasury Strategies
20.3.2025
Christian Angermayer, the firm’s chairman, stated that it will acquire $5 million in BTC
Binance Labs rebrands, dives into AI as CZ returns as mentor
23.1.2025
Former Binance CEO Changpeng Zhao will actively coach and mentor startups within the incubator